24 /100
LOW RISK
Score updated Jul 13, 2026

UTMD — Utah Medical Products, Inc. Dilution Risk Tracker

Track UTMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UTMD — Get alerts when the score changes →

As of July 13, 2026, Utah Medical Products, Inc. (UTMD) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. Utah Medical Products, Inc. has a market capitalization of $211.58M, 3.18M shares outstanding, 121 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
38
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for UTMD.
🔔 Track UTMD — Get forecast alerts →

💹 Market Data

Market Cap$211.58M
Shares Outstanding3.18M
Float2.77M
Cash$87.41M
Debt$210.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 22.3% shares (2026Q1 vs prior)
121 institutional holders · 2.61M shares
#1 BRANDES INVESTMENT PARTNERS, LP 449.3K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 277.1K shares
#3 DIMENSIONAL FUND ADVISORS LP 197.9K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest138.7K
Days to Cover6.8
% of Float5.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for UTMD Shareholders

Utah Medical Products, Inc. (UTMD) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for UTMD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for UTMD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for UTMD alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track UTMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UTMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for UTMD
📊 UTMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 UTMD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.